Jong, Miek C. http://orcid.org/0000-0001-8523-9632
van Wietmarschen, Herman http://orcid.org/0000-0003-2225-0337
Glockmann, Anja http://orcid.org/0000-0003-2257-3507
Baars, Erik W. http://orcid.org/0000-0003-4428-5135
Hamre, Harald J. http://orcid.org/0000-0003-1098-1079
Funding for this research was provided by:
Iona Foundation
BMC Software
Article History
Accepted: 14 May 2021
First Online: 28 July 2021
Declarations
:
: Financial support was received from two foundations, Iona Stichting (Amsterdam, The Netherlands) and Software AG-Stiftung (Darmstadt, Germany).
: ESCAMP has received funding from the AMP MAHs WALA Heilmittel GmbH and Weleda AG that provided data for this study. In accordance with the conflict-of-interest policy of ESCAMP (ExternalRef removed), sponsors had no influence on the planning or conduct of this study; the collection, preparation, analysis or interpretation of data for this article; nor on the preparation, review or approval of the article.
: According to the Ethics Committee in Brabant, The Netherlands (no. 18.430, 2018-10-10) this study did not involve experiments with patients or study subjects, according to the Dutch Medical Research in Human Subjects Act (WMO). Therefore, the study was exempt from further medical ethics review. The study protocol was registered in the Dutch Trial Database on 24 September 2018 (ExternalRef removed, NTR no. 7628).
: MAHs provided written informed consent to participate in the study.
: MAHs provided written informed consent for the results of the data analysis to be published.
: Raw data are non-public data obtained from WALA Heilmittel GmbH, Weleda AG, Helixor Heilmittel GmbH, and Iscador AG for the purposes of this study and the presentation of the results in the form of the tables presented in the publication.
: SPSS code used for the data analysis can be requested from the corresponding author.
: All authors were involved in the development of the study design and approved the study protocol. MJ was study coordinator, co-writer of the study protocol and statistical analysis plan, cross-checked data-entry and coding, calculated MDADs sold, interpreted study results, and wrote the manuscript. HvW calculated MDADs sold, performed statistical analyses and interpreted study results. AG entered, coded and prepared the data for analysis. EB was co-writer of the study protocol. HJH was co-writer of the study protocol and statistical analysis plan, interpreted study results and co-wrote the final manuscript. All authors read, commented on and approved the final manuscript.